Heart Rate Variability and Your Genetics

Written by Scott Peeples, BS Biomedical Sciences · ExomeDNA Founder Reviewed by ExomeDNA Editorial Process · [/methodology/editorial-process] Last reviewed: 2026-05-29

This page contains general information only. For personal health decisions, consult a qualified clinician.

Heart Rate Variability (HRV) — respiratory sinus arrhythmia is a measure of how efficiently the heart's pacing responds to each breath cycle, driven almost entirely by the vagus nerve. Genetic variants near HCN4, GNG11, and SYT10 have been linked to individual differences in this breathing-driven HRV signal in genome-wide research.^[1] Higher pvRSA/HF scores reflect stronger vagal-cardiac coupling — a marker that research consistently associates with cardiovascular resilience and stress recovery. Below: how the breath-heartbeat loop works, which genes shape it, and what you can do to work with your result.

What is Heart Rate Variability?

Heart Rate Variability (HRV) is a measure of the variation in time between consecutive heartbeats. While the heart beats in a rhythmic pattern, it does not beat like a metronome — healthy hearts speed up slightly during inhalation and slow down during exhalation, producing a natural oscillation in beat-to-beat timing. This oscillation is not random noise; it is a precisely regulated signal produced by the autonomic nervous system.

The metric at the center of this page — pvRSA/HF HRV — captures the specific component of that variation driven by breathing. The acronym breaks down as follows: pvRSA refers to the peak value of respiratory sinus arrhythmia, the name for the heart rate acceleration on inhale and deceleration on exhale. HF refers to the high-frequency band of HRV analysis (0.15–0.40 Hz), which aligns with normal breathing rates and is almost entirely a product of vagal (parasympathetic) nerve activity.

This makes pvRSA/HF the purest available non-invasive measure of vagal cardiac tone — the strength of the parasympathetic brake on the heart. It is distinct from other HRV metrics: RMSSD captures overall beat-to-beat vagal variation across short recordings, while SDNN captures total HRV across a full 24-hour period, blending both sympathetic and parasympathetic contributions. pvRSA/HF isolates the breathing-driven fraction.

Researchers and sports physiologists use HF HRV measured during controlled breathing as the research gold standard for assessing vagal cardiac tone. Because it is so tightly tied to breathing mechanics, it is highly responsive to breathing-based interventions — a key insight for anyone looking to improve their result.

The genetics behind Heart Rate Variability

Four genes from this trait's evidence base deserve specific attention. Each one participates in a distinct step of the per-breath vagal signaling cascade that generates the RSA oscillation.

HCN4 — the pacemaker channel and RSA effector

HCN4 encodes a hyperpolarization-activated cyclic nucleotide-gated channel that is the primary pacemaker current in the sinoatrial (SA) node — the heart's natural metronome. The HCN4 channel's open probability is directly regulated by cyclic AMP (cAMP): when cAMP levels rise, the channel opens more readily, speeding the pacemaker current; when cAMP falls, the channel slows. This cAMP sensitivity is precisely what creates the RSA oscillation. With each breath, vagal acetylcholine signaling modulates cAMP in the SA node, and HCN4 translates that per-breath signal into a corresponding per-beat speed change. Genetic variants in HCN4 affect the channel's baseline gating kinetics and its sensitivity to cAMP modulation, influencing how large the heart rate swing is for any given vagal input.

GNG11 — G protein signaling in the vagal cascade

GNG11 encodes the gamma-11 subunit of heterotrimeric G proteins — specifically the Gβγ component of the Gi signaling complex. When the vagus nerve releases acetylcholine onto cardiac M2 receptors with each exhalation, those receptors couple to Gi proteins. The Gi alpha subunit inhibits adenylyl cyclase, lowering cAMP; the Gβγ dimer (including GNG11-encoded gamma-11) simultaneously activates inwardly-rectifying potassium channels that hyperpolarize the SA node. GNG11 variants can influence the efficiency of this per-breath Gi coupling step, shaping how cleanly the vagal signal is transduced into a pacemaker response.

SYT10 — synaptotagmin and acetylcholine release precision

SYT10 encodes synaptotagmin-10, a calcium-sensing protein that regulates vesicle fusion at secretory synapses. At cardiac vagal nerve terminals, the timing and amplitude of acetylcholine release with each respiratory cycle determines the precision of the RSA signal. SYT10 variants that affect the calcium-dependent triggering threshold for vesicle fusion can subtly alter how much acetylcholine is released per breath cycle — and therefore how clean and large the RSA oscillation is at the SA node level.

NDUFA11 — mitochondrial energy in the SA node

NDUFA11 encodes a subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase). The SA node sustains high-frequency electrical oscillations around the clock and is metabolically demanding. Reliable mitochondrial ATP supply is prerequisite to stable, consistent pacemaker activity. NDUFA11 variants that affect Complex I assembly or efficiency can influence the energy budget of the SA node — and therefore the consistency and amplitude of its vagal responsiveness over time.

NEO1 — developmental wiring of the vagal pathway

NEO1 encodes neogenin, a cell-surface guidance receptor in the DCC/UNC-5 family that directs axon pathfinding during neural development. In the developing heart, cardiac vagal nerve fibers must navigate from the brainstem dorsal motor nucleus of the vagus to the SA node. NEO1 participates in this axon guidance process. Variants in NEO1 are thought to influence the completeness and precision of this developmental wiring — affecting, at a structural level, how efficiently the vagal pathway is established.

Genome-wide significant loci for pvRSA/HF HRV were identified in a large multi-cohort international study, with lead signals implicating genes in cardiac pacemaker function and autonomic signaling pathways.^[1]

What the research says

Research base: Moderate.

The genetic architecture of HRV has been examined in genome-wide association studies (GWAS) using large population cohorts. Nolte et al. (2017) published the most comprehensive GWAS of HRV traits to date, identifying genetic loci with effects on HRV measures including the high-frequency band and related respiratory sinus arrhythmia metrics, and demonstrating that these loci also carry effects on broader cardiac disease risk.^[1]

The biological coherence of the findings is noteworthy. Genes implicated at genome-wide significant loci are not randomly distributed across cellular function — they cluster in pathways directly relevant to pacemaker biology and autonomic cardiac control: ion channels (HCN4), G protein signaling (GNG11), calcium-dependent secretory vesicle regulation (SYT10), and mitochondrial energy metabolism (NDUFA11). This convergence of signal on mechanistically plausible genes strengthens confidence in the association findings.

HF HRV is estimated to be moderately heritable — meaning a meaningful portion of population variation in this trait reflects genetic differences between individuals, with environment, fitness, and behavior accounting for the remainder.^[1]

The moderate confidence tier for this trait reflects the current state of replication. The Nolte 2017 findings represent robust discovery-stage evidence for these loci, but the effect sizes of individual common variants are modest — consistent with the general pattern in complex trait genetics where many variants of small effect combine to shape an outcome. No single variant determines your pvRSA/HF result; your genetic profile represents one contributor among several.

Environmental factors — aerobic fitness, breathing habits, sleep quality, stress load, and autonomic nervous system training — account for substantial variance in pvRSA/HF independently of genetics. This is well-established in the exercise physiology and biofeedback literature, and represents the intervention opportunity described in the actionable section below.

How Heart Rate Variability affects you

pvRSA/HF HRV is not simply a measurement of cardiac health — it is a window into the functioning of the autonomic nervous system's parasympathetic branch. Because the vagus nerve is the shared highway for parasympathetic control of the heart, lungs, gut, and immune system, vagal tone as reflected in pvRSA/HF has correlates well beyond heart rate alone.

Cardiovascular resilience. Higher resting HF HRV is associated with better regulation of blood pressure responses to stress, faster heart rate recovery after exercise, and lower resting heart rate. These are all markers of efficient vagal cardiac control.

Stress response and emotional regulation. The polyvagal framework identifies high vagal tone as a physiological substrate for social engagement and stress recovery. People with higher resting HRV tend to show more flexible, calibrated stress responses — neither under-reactive nor over-reactive to challenges.

Athletic performance and recovery. Endurance athletes routinely track daily HRV (including HF HRV) as the most sensitive available signal of recovery status. A drop in morning HRV often precedes overtraining symptoms, injury risk, or illness — making it a practical early-warning measure for training load management.

Sleep and circadian biology. HF HRV peaks during slow-wave sleep, when vagal dominance is maximal. People with higher baseline vagal tone tend to have more restorative deep sleep, and conversely, poor sleep chronically suppresses HRV — creating a bidirectional relationship between sleep quality and vagal function.

Breathing efficiency. Because pvRSA/HF specifically measures the respiratory-cardiac coupling, it also reflects the mechanical efficiency of the respiratory system. Singers, wind instrument players, and practitioners of breathwork traditions tend to show elevated HF HRV — a direct consequence of training the precise breath-control muscles and rhythms that maximize RSA amplitude.

Your genetic result on this trait reflects baseline tendencies in how your vagal-cardiac axis is wired. A lower genetic score does not mean HRV intervention is futile — the environment-genetic interaction for this trait is favorable, meaning behavioral interventions have well-documented effects regardless of genetic starting point.

Working with your Heart Rate Variability result

The respiratory component of HRV is uniquely tractable because it is directly controlled by behavior — breathing rate, depth, and pattern are under voluntary command in a way that most physiological measures are not. This makes pvRSA/HF one of the most modifiable genetic trait results on the ExomeDNA platform.

The following interventions have the strongest evidence for improving HF HRV:

1. Resonant frequency (slow) breathing. Breathing at approximately 4.5–6 breaths per minute directly maximizes pvRSA/HF amplitude by entraining the heart rate oscillation to its natural RSA resonant frequency. Ten to twenty minutes per day of this practice, sustained over weeks, produces measurable increases in resting HF HRV. This is the most direct intervention available for this specific metric.

2. HRV biofeedback with coherent breathing. Wearable devices and apps (such as those using coherent breathing protocols) provide real-time feedback on HF HRV during slow breathing sessions. Biofeedback accelerates skill acquisition and helps individuals find their personal resonant frequency, which varies between approximately 4.5 and 7 breaths per minute.

3. Aerobic exercise training. Regular moderate-intensity aerobic exercise increases basal vagal tone and resting HF HRV, with effects that develop over weeks to months. Both the intensity and the consistency of training matter — sustained moderate exercise outperforms brief high-intensity-only protocols for vagal tone improvement.

4. Yoga and pranayama breathing practices. Specific breathing techniques including ujjayi (oceanic breath) and nadi shodhana (alternate nostril breathing) slow breathing rate and optimize RSA amplitude. These practices have been studied in controlled trials with consistent findings of HRV improvement.

5. Vocal and wind instrument training. Sustained vocal practice (singing, choir) and wind instrument playing require controlled exhalation over extended phrases, which trains the diaphragm and intercostal muscles to generate slow, deep respiratory cycles — the exact pattern that maximizes RSA. This is a real-world correlate of why musicians often show elevated HF HRV.

6. Sleep hygiene optimization. Because HF HRV peaks during deep sleep, any intervention that improves slow-wave sleep duration and quality will also raise average daily HF HRV. Consistent sleep timing, limiting alcohol (which fragments deep sleep), and managing sleep debt are the highest-leverage sleep variables.

People with a lower genetic score on this trait may find that their baseline HF HRV is lower than average even under good lifestyle conditions — this is the genetic contribution. The same individuals typically show robust responses to the interventions above, because the downstream signaling pathways (HCN4 cAMP sensitivity, GNG11 Gi coupling, SYT10 ACh release precision) are all modifiable by the autonomic tone changes that breathing and aerobic training produce.

Related traits and genes

HRV and cardiac rhythm sit at the intersection of several related trait categories on the ExomeDNA platform.

Sibling traits in cardiac rhythm and autonomic function:

• Resting Heart Rate — shares genetic architecture with HF HRV; HCN4 variants affect both resting HR and RSA amplitude
• Heart Rate Response to Exercise — reflects sympathetic activation; inversely related to vagal tone at rest
• Heart Rate Recovery After Exercise — the speed of HR drop post-exercise is a direct measure of vagal reactivation; closely linked to HF HRV biology

Cross-category related traits:

• Stress Reactivity — vagal tone is a primary physiological substrate of autonomic stress regulation; HF HRV and stress reactivity share mechanisms
• Sleep Quality — bidirectional relationship; vagal dominance during deep sleep drives HF HRV peaks; sleep disruption suppresses daytime HRV

Frequently asked questions

What does pvRSA/HF mean on my ExomeDNA result? pvRSA stands for peak value of respiratory sinus arrhythmia — the amplitude of the heart rate swing that occurs with each breath. HF refers to the high-frequency band (0.15–0.40 Hz) of HRV analysis, which captures this breathing-driven oscillation. Your result reflects how your genetic variants are associated with population-level differences in this metric. Higher scores are associated with stronger vagal-cardiac coupling.

Is HF HRV the same as regular HRV? HRV is an umbrella term covering multiple metrics. HF HRV (and pvRSA) specifically captures the breathing-driven component — the part of HRV that oscillates in sync with respiratory rate. Other metrics like RMSSD capture overall short-term vagal variation, and SDNN captures total 24-hour variation blending both sympathetic and parasympathetic contributions. HF HRV is considered the purest measure of vagal cardiac tone.

Can I actually improve my HRV, or is it fixed by genetics? Genetics set a baseline tendency, but HF HRV is among the most modifiable measures available. Slow breathing at 4.5–6 breaths per minute immediately raises HF HRV amplitude, and consistent aerobic training raises resting levels over weeks to months. Lower genetic scores do not cap the response — interventions work regardless of starting point.

Why does breathing rate matter so much for HF HRV? The high-frequency band (0.15–0.40 Hz) corresponds to breathing rates of roughly 9–24 breaths per minute. When you slow your breathing to around 5–6 breaths per minute, your heart rate oscillations move toward the lower edge of — or just below — the HF band, maximizing the RSA amplitude. This is why slow diaphragmatic breathing is the most direct intervention for this specific metric, and why pranayama and coherent breathing practices are so reliably effective.

Does a lower HRV score mean something is wrong with my heart? No. This result reflects population-level genetic associations with a physiological measure — it is not a cardiac condition indicator. Lower HF HRV in healthy people is common and tied to modifiable factors: fitness, stress, and breathing habits. ClinVar lists pathogenic HCN4 variants linked to rare arrhythmia syndromes, but those are distinct from the common population variants in this GWAS result. For cardiac concerns, consult a clinician.

References

1. Nolte IM et al. Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nature Communications. 2017. PMID: 28613276. DOI: 10.1038/ncomms15805.

Data sources:

• GWAS Catalog (NHGRI-EBI, accessed 2026-05-20)
• Open Targets Platform (CC0 1.0, accessed 2026-05-20)
• ClinVar (NCBI, accessed 2026-05-20) — entries at 2-star review status or above
• ClinGen Gene-Disease Validity (CC0 1.0, accessed 2026-05-20)

ExomeDNA genetic results are for wellness and educational purposes only. Consult a clinician for personalized health guidance.